GR-MD-02
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for GR-MD-02, covering 2015-02-23 to 2020-10-08. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis [Phase 2]